PRELUDE THERAPEUTICS INC (PRLD) Free cash flow 2019–2025
PRELUDE THERAPEUTICS INC (PRLD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$56.4MFY2025 · since FY2019: -$26.4M → -$56.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$56.4M | +45.6% |
| FY2024 | -$103.7M | +6.3% |
| FY2023 | -$110.6M | -27.5% |
| FY2022 | -$86.7M | -1.0% |
| FY2021 | -$85.9M | -83.5% |
| FY2020 | -$46.8M | -77.0% |
| FY2019 | -$26.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PRLD financial trends
PRLD RevenuePRLD Net incomePRLD Net marginPRLD Gross profitPRLD Gross marginPRLD Operating incomePRLD Operating marginPRLD Operating cash flowPRLD Capital expendituresPRLD Return on equityPRLD Stock buybacksPRLD Dividends paidPRLD Total assetsPRLD Total liabilitiesPRLD Shareholders’ equityPRLD overview →